Steven Joniau

Steven Joniau

Brasschaat, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 373 publications

Overall Survival After Hormones and Radiotherapy Postprostatectomy: Relevant End Point or Overrated?

Overall Survival After Hormones and Radiotherapy Postprostatectomy: Relevant End Point or Overrated?

Journal: European urology
Published: July 23, 2026

PROTEUS Pushes the Paradigm.

PROTEUS Pushes the Paradigm.

Journal: European urology
Published: June 16, 2026

Oligometastatic prostate cancer - bridging the gap between localized and metastatic disease.

Oligometastatic prostate cancer - bridging the gap between localized and metastatic disease.

Journal: Nature reviews. Urology
Published: March 31, 2026

External validation and comparison of nomograms for prediction of long-term disease recurrence and survival for bladder cancer patients who undergo radical cystectomy.

External validation and comparison of nomograms for prediction of long-term disease recurrence and survival for bladder cancer patients who undergo radical cystectomy.

Journal: Minerva urology and nephrology
Published: February 27, 2026

Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate Cancer.

Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate Cancer.

Journal: JAMA oncology
Published: February 12, 2026

Transcriptomic profiling across stages of non-muscle-invasive bladder cancer identifies fibroblast activation protein-alpha as a stromal biomarker associated with progression.

Transcriptomic profiling across stages of non-muscle-invasive bladder cancer identifies fibroblast activation protein-alpha as a stromal biomarker associated with progression.

Journal: Molecular medicine (Cambridge, Mass.)
Published: February 06, 2026

Prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: does it really have an effect on oncological outcomes?

Prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: does it really have an effect on oncological outcomes?

Journal: BJU international
Published: December 23, 2025

ERG orchestrates a dedifferentiation-senescence-inflammation triad in prostate cancer.

ERG orchestrates a dedifferentiation-senescence-inflammation triad in prostate cancer.

Journal: Molecular cancer research : MCR
Published: November 28, 2025

Multi-omics integration and batch correction using a modality-agnostic deep learning framework.

Multi-omics integration and batch correction using a modality-agnostic deep learning framework.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Hematological Toxicity and Bone Marrow Dose-Volume Effects in Chemotherapy-Naïve Patients Treated With Whole Pelvic and Para-aortic Lymph Node Radiation Therapy For Pathologic Pelvic Lymph Node-Positive Prostate Cancer.

Hematological Toxicity and Bone Marrow Dose-Volume Effects in Chemotherapy-Naïve Patients Treated With Whole Pelvic and Para-aortic Lymph Node Radiation Therapy For Pathologic Pelvic Lymph Node-Positive Prostate Cancer.

Journal: Advances in radiation oncology
Published: October 14, 2025

Final Results of the Randomised Phase 2 Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer (ARNEO).

Final Results of the Randomised Phase 2 Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer (ARNEO).

Journal: European urology oncology
Published: September 29, 2025

Prognostic and Predictive Value of the Clearseq1-4 Tumor Microenvironment Classification in Localized and Metastatic Clear-Cell Renal Cell Carcinoma.

Prognostic and Predictive Value of the Clearseq1-4 Tumor Microenvironment Classification in Localized and Metastatic Clear-Cell Renal Cell Carcinoma.

Journal: Cancer research communications
Published: September 10, 2025
Showing 1-12 of 373

Last Updated: 09/26/2026